455 related articles for article (PubMed ID: 9347984)
1. Reversal and prevention of cerebral vasospasm by intracarotid infusions of nitric oxide donors in a primate model of subarachnoid hemorrhage.
Pluta RM; Oldfield EH; Boock RJ
J Neurosurg; 1997 Nov; 87(5):746-51. PubMed ID: 9347984
[TBL] [Abstract][Full Text] [Related]
2. Increased cerebral blood flow but no reversal or prevention of vasospasm in response to L-arginine infusion after subarachnoid hemorrhage.
Pluta RM; Afshar JK; Thompson BG; Boock RJ; Harvey-White J; Oldfield EH
J Neurosurg; 2000 Jan; 92(1):121-6. PubMed ID: 10616090
[TBL] [Abstract][Full Text] [Related]
3. Effect of intracarotid nitric oxide on primate cerebral vasospasm after subarachnoid hemorrhage.
Afshar JK; Pluta RM; Boock RJ; Thompson BG; Oldfield EH
J Neurosurg; 1995 Jul; 83(1):118-22. PubMed ID: 7782826
[TBL] [Abstract][Full Text] [Related]
4. Temporal changes in perivascular concentrations of oxyhemoglobin, deoxyhemoglobin, and methemoglobin after subarachnoid hemorrhage.
Pluta RM; Afshar JK; Boock RJ; Oldfield EH
J Neurosurg; 1998 Mar; 88(3):557-61. PubMed ID: 9488312
[TBL] [Abstract][Full Text] [Related]
5. Endothelial dysfunction in a primate model of cerebral vasospasm.
Iuliano BA; Pluta RM; Jung C; Oldfield EH
J Neurosurg; 2004 Feb; 100(2):287-94. PubMed ID: 15086237
[TBL] [Abstract][Full Text] [Related]
6. Effects of nitroglycerin on vasospasm and cyclic nucleotides in a primate model of subarachnoid hemorrhage.
Nakao K; Murata H; Kanamaru K; Waga S
Stroke; 1996 Oct; 27(10):1882-7; discussion 1887-8. PubMed ID: 8841348
[TBL] [Abstract][Full Text] [Related]
7. Nitrite infusions to prevent delayed cerebral vasospasm in a primate model of subarachnoid hemorrhage.
Pluta RM; Dejam A; Grimes G; Gladwin MT; Oldfield EH
JAMA; 2005 Mar; 293(12):1477-84. PubMed ID: 15784871
[TBL] [Abstract][Full Text] [Related]
8. Time course of the impairment of cerebral autoregulation during chronic cerebral vasospasm after subarachnoid hemorrhage in primates.
Handa Y; Hayashi M; Takeuchi H; Kubota T; Kobayashi H; Kawano H
J Neurosurg; 1992 Mar; 76(3):493-501. PubMed ID: 1738032
[TBL] [Abstract][Full Text] [Related]
9. Role of ferrous iron chelator 2,2'-dipyridyl in preventing delayed vasospasm in a primate model of subarachnoid hemorrhage.
Horky LL; Pluta RM; Boock RJ; Oldfield EH
J Neurosurg; 1998 Feb; 88(2):298-303. PubMed ID: 9452239
[TBL] [Abstract][Full Text] [Related]
10. Is vasospasm related to proliferative arteriopathy?
Pluta RM; Zauner A; Morgan JK; Muraszko KM; Oldfield EH
J Neurosurg; 1992 Nov; 77(5):740-8. PubMed ID: 1403117
[TBL] [Abstract][Full Text] [Related]
11. Intracisternal versus intracarotid infusion of L-arginine in experimental cerebral vasospasm.
Ozüm U; Aslan A; Karadağ O; Gürelik M; Taş A; Zafer Kars H
J Clin Neurosci; 2007 Jun; 14(6):556-62. PubMed ID: 17430779
[TBL] [Abstract][Full Text] [Related]
12. Loss of nitric oxide synthase immunoreactivity in cerebral vasospasm.
Pluta RM; Thompson BG; Dawson TM; Snyder SH; Boock RJ; Oldfield EH
J Neurosurg; 1996 Apr; 84(4):648-54. PubMed ID: 8613858
[TBL] [Abstract][Full Text] [Related]
13. Sphenopalatine ganglion stimulation for vasospasm after experimental subarachnoid hemorrhage.
Takahashi M; Zhang ZD; Macdonald RL
J Neurosurg; 2011 Apr; 114(4):1104-9. PubMed ID: 20597600
[TBL] [Abstract][Full Text] [Related]
14. Etiology of cerebral vasospasm in primates.
Macdonald RL; Weir BK; Runzer TD; Grace MG; Findlay JM; Saito K; Cook DA; Mielke BW; Kanamaru K
J Neurosurg; 1991 Sep; 75(3):415-24. PubMed ID: 1869943
[TBL] [Abstract][Full Text] [Related]
15. Association between cerebrospinal fluid levels of asymmetric dimethyl-L-arginine, an endogenous inhibitor of endothelial nitric oxide synthase, and cerebral vasospasm in a primate model of subarachnoid hemorrhage.
Jung CS; Iuliano BA; Harvey-White J; Espey MG; Oldfield EH; Pluta RM
J Neurosurg; 2004 Nov; 101(5):836-42. PubMed ID: 15543672
[TBL] [Abstract][Full Text] [Related]
16. Effect of cyclosporine on the development of cerebral vasospasm in a primate model.
Handa Y; Hayashi M; Takeuchi H; Kobayashi H; Kawano H; Kabuto M
Neurosurgery; 1991 Mar; 28(3):380-5; discussion 385-6. PubMed ID: 2011219
[TBL] [Abstract][Full Text] [Related]
17. Reversal of cerebral vasospasm using an intrathecally administered nitric oxide donor.
Wolf EW; Banerjee A; Soble-Smith J; Dohan FC; White RP; Robertson JT
J Neurosurg; 1998 Aug; 89(2):279-88. PubMed ID: 9688124
[TBL] [Abstract][Full Text] [Related]
18. Prospective, randomized, double-blind trial of BQ-123 and bosentan for prevention of vasospasm following subarachnoid hemorrhage in monkeys.
Hino A; Weir BK; Macdonald RL; Thisted RA; Kim CJ; Johns LM
J Neurosurg; 1995 Sep; 83(3):503-9. PubMed ID: 7666230
[TBL] [Abstract][Full Text] [Related]
19. The effect of timing of clot removal on chronic vasospasm in a primate model.
Handa Y; Weir BK; Nosko M; Mosewich R; Tsuji T; Grace M
J Neurosurg; 1987 Oct; 67(4):558-64. PubMed ID: 3655894
[TBL] [Abstract][Full Text] [Related]
20. Reversal of cerebral vasospasm via intravenous sodium nitrite after subarachnoid hemorrhage in primates.
Fathi AR; Pluta RM; Bakhtian KD; Qi M; Lonser RR
J Neurosurg; 2011 Dec; 115(6):1213-20. PubMed ID: 21888479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
